COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,669 Articles (22,913 medRxiv, 8,756 bioRxiv)

Most recent first Previous |  Page 1457: Articles 14561-14570  | Next

Highly-Neutralizing COVID-19-Convalescent-Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Takamatsu, Y., Imai, M., Maeda, K., Nakajima, N., Higashi-Kuwata, N., Iwatsuki-Horimoto, K., Ito, M., Kiso, M., Maemura, T., Takeda, Y., Omata, K., Suzuki, T., Kawaoka, Y., Mitsuya, H.
10.1101/2021.06.29.450453 — Posted: 2021-06-30
Comparative computational modeling of the bat and human immune response to viral infection with the Comparative Biology Immune Agent Based Model
Cockrell, C., An, G.
10.1101/2021.06.29.450378 — Posted: 2021-06-30
Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
Cromer, D., Reynaldi, A., Steain, M., Triccas, J. A., Davenport, M. P., Khoury, D. S.
10.1101/2021.06.29.21259504 — Posted: 2021-06-30
A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: Ongoing symptomatic phase vs. post-COVID-19 syndrome
Jennings, G., Monaghan, A., Xue, F., Mockler, D., Romero-Ortuno, R.
10.1101/2021.06.25.21259372 — Posted: 2021-06-30
Age reporting in the Brazilian COVID-19 vaccination database: What can we learn from it?
Turra, C. M., Fernandes, F., Calazans, J., Nepomuceno, M.
10.1101/2021.06.27.21259575 — Posted: 2021-06-30
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness
Ke, R., Zitzmann, C., Ho, D. D., Ribeiro, R., Perelson, A. S.
10.1101/2021.06.26.21259581 — Posted: 2021-06-30
Resurgence of SARS-CoV-2 in India: Potential role of the B.1.617.2 (Delta) variant and delayed interventions
Salvatore, M., Bhattacharyya, R., Purkayastha, S., Zimmermann, L., Ray, D., Hazra, A., Kleinsasser, M., Mellan, T. A., Whittaker, C., Flaxman, S., Bhatt, S., Mishra, S., Mukherjee, B.
10.1101/2021.06.23.21259405 — Posted: 2021-06-30
A Systematic Review: The Dimensions and Indicators utilized in the Performance Evaluation of Health Care Organizations- An Implication during COVID-19 Pandemic
Amer, F., Hammoud, S., Khatatbeh, H., Lohner, S., Boncz, I., Endrei, D.
10.1101/2021.06.26.21259568 — Posted: 2021-06-30
Altered cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.
Apostolidis, S. A., Kakara, M., Painter, M. M., Goel, R. R., Mathew, D., Lenzi, K., Rezk, A., Patterson, K. R., Espinoza, D. A., Kadri, J. C., Markowitz, D. M., Markowitz, C., Mexhitaj, I., Jacobs, D., Babb, A., Betts, M. R., Luning Prak, E. T., Weiskopf, D., Grifoni, A., Lundgreen, K. A., Gouma, S., Sette, A., Bates, P., Hensley, S. E., Greenplate, A. R., Wherry, E. J., Li, R., Bar-Or, A.
10.1101/2021.06.23.21259389 — Posted: 2021-06-30
The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort
Preston, N. J., Parkin, A., Makower, S., Ross, D. H., Gee, J., Halpin, S. J., Horton, M. C., O'Connor, R. J., Sivan, M.
10.1101/2021.06.28.21259613 — Posted: 2021-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).